Literature DB >> 8484674

Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density.

G M Hall1, L A Perry, T D Spector.   

Abstract

The sex hormones dehydroepiandrosterone sulphate (DHEAS), oestradiol, and sex hormone binding globulin (SHBG) were measured in 185 postmenopausal women (aged 45-65 years) with rheumatoid arthritis (RA) and related to assessments of bone mineral density at the spine and proximal femur. Compared with 518 postmenopausal control women (aged 45-65 years), DHEAS levels were below normal in the 120 patients with RA who had never taken corticosteroids and levels were further depressed in 39 patients currently using steroids. Twenty six patients who had completed steroid treatment also had lower DHEAS levels, suggesting a delayed recovery of adrenal androgen secretion. Oestradiol and SHBG levels were similar in all groups. There was no correlation between sex hormones and disease activity. Oestradiol correlated with bone mineral density at all sites. Although oestradiol correlated with DHEAS, there was no relation between DHEAS and bone mineral density. The cause of below normal levels of DHEAS in RA is unclear, whether a consequence of chronic illness, immune dysfunction, or a defect of adrenal androgen synthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8484674      PMCID: PMC1005019          DOI: 10.1136/ard.52.3.211

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  Androgenic status and sexual function in males with rheumatoid arthritis and ankylosing spondylitis.

Authors:  D Gordon; G H Beastall; J A Thomson; R D Sturrock
Journal:  Q J Med       Date:  1986-07

2.  Role of ACTH in the secretion of free dehydroepiandrosterone and its sulfate ester in man.

Authors:  J L Vaitukaitis; S L Dale; J C Melby
Journal:  J Clin Endocrinol Metab       Date:  1969-11       Impact factor: 5.958

3.  Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood.

Authors:  H L Judd; G E Judd; W E Lucas; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

4.  Metabolism and interconversion of dehydroisoandrosterone and dehydroisoandrosterone sulfate.

Authors:  R S Rosenfeld; L Hellman; T F Gallagher
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

5.  The hormonal activity of the postmenopausal ovary.

Authors:  A Vermeulen
Journal:  J Clin Endocrinol Metab       Date:  1976-02       Impact factor: 5.958

6.  Sex hormone status in women suffering from rheumatoid arthritis.

Authors:  M Cutolo; E Balleari; M Giusti; M Monachesi; S Accardo
Journal:  J Rheumatol       Date:  1986-12       Impact factor: 4.666

Review 7.  Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion.

Authors:  A T Masi; D B Josipović; W E Jefferson
Journal:  Semin Arthritis Rheum       Date:  1984-08       Impact factor: 5.532

8.  The relation between calcium absorption, serum dehydroepiandrosterone, and vertebral mineral density in postmenopausal women.

Authors:  B E Nordin; A Robertson; R F Seamark; A Bridges; J C Philcox; A G Need; M Horowitz; H A Morris; S Deam
Journal:  J Clin Endocrinol Metab       Date:  1985-04       Impact factor: 5.958

9.  Endogenous sex steroid levels in women with generalised osteoarthritis.

Authors:  T D Spector; L A Perry; R W Jubb
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

10.  Interrelationship between the immunological and steroid hormone parameters in rheumatoid arthritis.

Authors:  K G Fehér; T Fehér; K Merétey
Journal:  Exp Clin Endocrinol       Date:  1986-06
View more
  6 in total

1.  A study of serum androgen and cortisol levels in female patients with rheumatoid arthritis. Correlation with disease activity.

Authors:  L Mirone; L Altomonte; P D'Agostino; A Zoli; A Barini; M Magaro
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

2.  Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE).

Authors:  T Suzuki; N Suzuki; E G Engleman; Y Mizushima; T Sakane
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

3.  Serum androgen-anabolic hormones and the risk of rheumatoid arthritis.

Authors:  R Heikkilä; K Aho; M Heliövaara; P Knekt; A Reunanen; A Aromaa; A Leino; T Palosuo
Journal:  Ann Rheum Dis       Date:  1998-05       Impact factor: 19.103

Review 4.  Epidemiology and burden of illness of rheumatoid arthritis.

Authors:  Tore K Kvien
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

5.  Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients.

Authors:  M Nishio; F Ohyanagi; A Horiike; Y Ishikawa; Y Satoh; S Okumura; K Nakagawa; K Nishio; T Horai
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

6.  Large Scale Metabolic Profiling identifies Novel Steroids linked to Rheumatoid Arthritis.

Authors:  Noha A Yousri; Karim Bayoumy; Wessam Gad Elhaq; Robert P Mohney; Samar Al Emadi; Mohammed Hammoudeh; Hussein Halabi; Basel Masri; Humeira Badsha; Imad Uthman; Robert Plenge; Richa Saxena; Karsten Suhre; Thurayya Arayssi
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.